An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration

2007969 citationsJournal Article

Authors

Good health and well-being

Published in: American Journal of Ophthalmology

Volume 143, Issue 4, pp. 566-583.e2

Field-Weighted Citation Impact: 76.55